Flagship Pioneering, Inc. - Associate Scientist, in vitro Pharmacology and Assay Development

• Essential • Experience operating in a consulting, interim, or fractional HR leadership capacity strongly preferred • Deep knowledge of UK employment law and HR best practices • Demonstrated ability to operate effectively within an established HR governance structure • Experience aligning local HR execution with global strategy • Strong employee relations and leadership coaching expertise • Ability to work independently while remaining highly collaborative and integrated • Excellent communication and stakeholder management skills • Desirable • Experience within life sciences, biotech, or high-growth organizations • Experience working with US-based leadership teams • Chartered MCIPD qualification or equivalent experience • Experience supporting scientific or technical populations • Prior exposure to venture-backed or early-stage environments • Values and Behaviors: • Encourage respectful disagreement and cultivate open-minded, ego-free interactions to continuously push each other towards excellence • Seek out diverse perspectives; practice active listening and genuine curiosity to ensure all contributions are valued, regardless of source • Recognize the impact of your behavior, language and attitudes, and strive for balanced, meaningful exchanges that enhance mutual growth and understanding in all interactions • Use a company-first mindset to guide decision-making; prioritize team over individual success • Take calculated risks and challenge convention in the quest for exceptional outcomes • Quotient Therapeutics is a privately-held, early stage company developing breakthrough medicines informed by natural somatic genetic diversity present in patients. Through our work in somatic genomics, we are forging a new status quo for biopharma research and development across a broad pipeline of internal and partnered programs. • The company was founded by Flagship Pioneering, an innovative enterprise that conceives, creates, resources, and grows first-in-category life sciences companies. Flagship Pioneering has created over 100 groundbreaking companies over the past twenty years, all of which are pioneering novel and proprietary biological, industrial, and engineering approaches to solve major needs in human health and sustainability. These companies include Moderna (MRNA), Generate Biomedicines, Sana Biotechnology (SANA), Tessera Therapeutics, Evelo Biosciences (EVLO), Indigo Agriculture, Seres Therapeutics (MCRB), and Syros Pharmaceuticals (SYRS). • Quotient Therapeutics and Flagship Pioneering are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status.